维梧资本完成超7.4亿美元公开市场基金募集

Group 1 - Vivo Capital announced the completion of fundraising for its Vivo Opportunity Fund III and related funds, collectively referred to as the "public market fund," with a total subscription amount exceeding $740 million [1] - The fund will focus on investing in life sciences companies that are in preclinical and clinical development stages [1] - The investment period for the fund is set for three years [1]